Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
FBIOP · against 588 other Healthcare companies listed in US-listed
Ranked #52 of 589 · scores higher than 91% of peers
Bars: peers in each 10-point band of the valuation score27 peers with a valuation score of 80–89, including FBIOP · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | FBIOP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -5.8% | -4.3% | 46% | 30% | |
| EBITDA yieldHigher is better · 578 reported | -6.2% | -0.8% | 37% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | Not reported | -2.3% | — | — | 20% |
| Book yieldHigher is better · 587 reported | 33.0% | 25.9% | 59% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 49 | 2.5B USD | 81 | 79 | |
| 49 | 2.5B USD | 81 | 60 | |
| 49 | 296M USD | 81 | 66 | |
| 52 | 1.7B USD | 80 | 44 | |
| 52 | Unavailable | 80 | 56 | |
| 52 | 1.8B USD | 80 | 80 | |
| 52 | 2.3B USD | 80 | 52 | |
| 56 | 320M USD | 79 | 44 | |
| 56 | 418M USD | 79 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score